Biophan allies with Boston Scientific

Article

Biophan Technologies has entered into a joint development agreement with Boston Scientific to create a variety of devices that are safe and compatible with MRI. The two companies will also explore possible licensing agreements under the alliance. The

Biophan Technologies has entered into a joint development agreement with Boston Scientific to create a variety of devices that are safe and compatible with MRI. The two companies will also explore possible licensing agreements under the alliance. The joint development agreement will support R&D aimed at resolving problems caused by the interference that results from metal objects in the field-of-view of MR scanners. This interference can obscure tissue and raise safety concerns. Biophan has developed a coating technology that reduces image interference caused by metal objects. It is also developing implantable devices, such as cardiac pacemakers, that are MR-compatible.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.